Assessing the risk of secondary leukemia in patients treated for Hodgkin's disease - A report from the international database on Hodgkin's disease

Journal of Biological Systems

Volumn 5, Issue 3, 1997, Pages 433-444

  Tsodikov, A D ^a   Loeffler, M ^b   Yakovlev, A Yu ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Hodgkin's disease; Parametric models; Risk prediction; Secondary leukemia

Indexed keywords

EID: 0004786125     PISSN: 02183390     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0218339097000266     Document Type: Article

References (16)

1. Henry-Amar M., Workshop statistical report. In: Treatment Strategy in Hodgkin's Disease. Colloque INSERM 196. Edited by Somers R., Henry-Amar M., Meerwaldt J. K. and Carde P. (John Libbey EUROTEXT, London-Paris, 1990) pp. 169-418.
2. Henry-Amar M. and Somers R., Survival outcome after Hodgkin's disease: A report from the International Data Base on Hodgkin's Disease, Seminars in Oncology 17 (1990) pp. 758-768.
3. Blayney D. W., Longo D. L., Young R. C. et al., Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease, New Engl. J. Med. 316 (1987) pp. 710-714. (Workshop statistical report).
4. Carnellos G. P., James M. D., Anderson J. R. et al., Chemotherapy of advanced Hodgkin's Disease with MOPP, ABVD, or MOPP alternating with ABVD, New Engl. J. Med. 327 (1992) pp. 1478-1484.
5. DeVita V. T., Hellman S. and Jaffe E. S., Hodgkin's Disease. In: Cancer. Principles and Practice of Oncology. Edited by V. T. DeVita V. T., Hellman S. and Rosenberg S. A. (J. B. Lippincott Company, Philadelphia, 1993).
6. Hoang T., Tsodikov A., Yakovlev A. and Asselain B., Modelling breast cancer recurrence. In: Mathematical Population Dynamics: Analysis of Heterogeneity, Vol. 2: Carcinogenesis and Cell and Tumor Growth, pp. 283-296. Edited by Arino O., Axelrod D. and Kimmel M. (Wuerz Publications, Winnipeg, Manitoba, Canada, 1995).
7. Kaldor J. M. and Lasset C., Second malignancies following Hodgkin's disease. In: Treatment Strategy in Hodgkin's Disease. Colloque INSERM 196 (1990) pp. 139-150. Edited by Somers R., Henry-Amar M., Meerwaldt J. K. and Carde P. (John Libbey EUROTEXT, London-Paris).
8. Keating M. J., Estey E. and Kantarjian H., Acute leukemia. In: Cancer. Principles and practice of oncology. Edited by DeVita V. T., Hellman S. and Rosenberg S. A. (J. B. Lippincott Company, Philadelphia, 1993).
9. Klebanov L. B., Rachev S. T. and Yakovlev A. Yu., A stochastic model of radiation carcinogenesis: latent time distributions and their properties, Math. Biosci. 113 (1993) pp. 51-75.
10. Kopp-Schneider A., Mechanistic models in QRA: Cell kinetic approaches, Informatik, Biometrie und Epidemiologie in Medizin und Biologie 25 (1994) pp. 242-249.
11. Longo D. L., The use of chemotherapy in the treatment of Hodgkin's disease, Seminars in Oncology 17 (1990) pp. 758-768.
12. Tsodikov A., A proportional hazards model taking account of long-term survivors, submitted to Biometrics (1996).
13. Tyurin Yu. N., Yakovlev A. Yu., Shi J. and Bass L., Testing a model of aging in animal experiments, Biometrics 51 (1995) pp. 363-372.
14. Yakovlev A. and Tsodikov A., Stochastic Models of Tumor Latency and Their Biostatistical Applications, World Scientific Publisher, Singapore, 1996.
15. Yakovlev A. Yu., Tsodikov A. D. and Anisimov V. N., A new model of aging: Specific versions and their application, Biometrical Journal 37 (1995) pp. 435-448.
16. Yakovlev A. Yu., Tsodikov A. D. and Bass L., A stochastic model of hormesis, Math. Biosci. 116 (1993) pp. 197-219.